Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1976-4-29
pubmed:abstractText
Reticuloendothelial (RE) phagocytic and circulating plasma opsonic activity was evaluated in rats transplanted with the Walker 256 carcinoma tumour in an attempt to evaluate the role of opsonic protein in governing the functional state of the macrophage system. Animals transplanted intramuscularly with 2 X 10(4) viable tumour cells manifested 2 peaks of RE stimulation at 6 and 14 days post-transplantation with a subsequent decline in the phagocytic activity over the 14-30 day period. Increased phagocytic activity as determined by colloid clearance was primarily a reflection of hepatic Küpffer cell hyperphagocytosis while the decline in phagocytic activity was related to a decrease in Küpffer cell function. The initial peak of RE stimulation was associated with an elevation in the blood opsonin level and no significant enlargement of the liver and spleen. In contrast, the second peak of RE stimulation at 14 days was associated with both an elevation in opsonin levels and an associated hepatic and splenic enlargement. The decline in phagocytic activity over the 14-30 day interval was associated with a progressive decline in the plasma opsonic activity, a return of the spleen to its normal size in relationship to the body weight, and a persistent hepatomegaly. These findings suggest that the alterations in macrophage function during tumour growth may be mediated in part by changes in the opsonic or phagocytosis promoting capacity of plasma. Since opsonic protein contributes to the discriminatory capacity of macrophages, it is suggested that changes in the blood opsonin level may condition the anti-tumour capacity of the macrophage system with respect to host defence aginst malignant disease.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-13097134, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-13534069, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-13730687, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-14027893, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-14094297, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-14150409, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-14155797, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-14428599, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-14481701, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-4130373, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-4147951, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-4419513, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-4704232, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-4921754, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-5026957, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-5029149, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-5060134, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-5440399, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-5463908, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-5765581, http://linkedlifedata.com/resource/pubmed/commentcorrection/1212411-5884843
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0007-0920
pubmed:author
pubmed:issnType
Print
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
471-82
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed:year
1975
pubmed:articleTitle
Humoral mediated macrophage response during tumour growth.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.